PNB defrauded of Rs 3805 crore, stock crashes 11 per cent
PNB defrauded of Rs 3805 crore, stock crashes 11 per cent

PNB defrauded of Rs 3805 crore, stock crashes 11 per cent

Nidhi Jani Article rating: 5.0

Although the account was already NPA in its books, the bank has so far only made provisions amounting to Rs.1932.47 crore, which is nearly half of the amount of the NPA.

JK Tyre slips on ratings downgrade
JK Tyre slips on ratings downgrade

JK Tyre slips on ratings downgrade

Nidhi Jani Article rating: 5.0

The downward revision was triggered by the lower-than-expected cash accruals, leading to low coverage and return indicators and slower than expected deleveraging at the consolidated level, which has led to weakening of the company’s overall financial and liquidity profile.

Red is the colour of the day post budget!
Red is the colour of the day post budget!

Red is the colour of the day post budget!

Shohini Nath Article rating: 5.0

In the afternoon, all the sectoral indices were trading in the negative territory while the Sensex was down 1.9 per cent and Nifty 50 was down 2.32 per cent. On the back of sustained selling by market-participants, the markets are continuing their negative momentum as the equity markets were trading at the day’s low points in the afternoon session.

Biocon gets USFDA observations
Biocon gets USFDA observations

Biocon gets USFDA observations

Geyatee Deshpande Article rating: 5.0

Biocon has been issued 12 observations by the USFDA for its assembly facilities in Malaysia. Despite the news, the stock price of the company increased by 1.5 per cent.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 5.0

The markets on July 08, 2019 opened gap down. BSE Sensex is trading at 38,888.00, down by 625.39 points and the Nifty is trading at 11,617.45, down by 193.70 points. 

SPARC gets USFDA approval to treat Leukemia
SPARC gets USFDA approval to treat Leukemia

SPARC gets USFDA approval to treat Leukemia

Nidhi Jani Article rating: 4.7

Orphan Drug Designation will grant seven years of US market exclusivity upon approval of SCO-088 for the treatment of patients with CML. Incentives include waiver of user fee by USFDA and assistance in clinical trial design by USFDA.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 3.3

Overall volumes in futures & options currently stand at 1,43,24,430 contracts with a turnover of Rs.10,46,886.87 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1,43,24,430 contracts with a turnover of Rs.10,46,886.87 crore.

Index trend and stocks in action July 08, 2019
Index trend and stocks in action July 08, 2019

Index trend and stocks in action July 08, 2019

Karan Dsij Article rating: 5.0

It would be interesting to see whether or not bulls manage to hold on to the budget session low of (11,798). If they manage to hold above this level, the pullback options would remain open towards the levels of 11,880-11,940. However, failure to hold the support level of 11,798 would result in a prolonged correction towards the next important support level of 11,726, which is 50-DMA. Stocks in news: India Grid Trust, PNB Housing, PNB, Indian Hume Pipe, JSW Energy, Zuari Agro Chemicals, Yes Bank, Quick Heal Technologies, Tata Power, JSW Steel, Maruti Suzuki.

RSS
First25172518251925202522252425252526Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR